Appel Susan J, Wadas Theresa M, Andrabi Mudasir S
J Nurse Pract. 2021 Jun;17(6):680-686. doi: 10.1016/j.nurpra.2020.12.021. Epub 2021 Feb 15.
The dual pandemics of coronavirus disease-19 (COVID-19) and diabetes among patients are associated with 2- to 3-times higher intensive care admissions and higher mortality rates. Whether sheltering at home, quarantined with a positive COVID-19 test, or hospitalized, the person living with diabetes needs special considerations for successful management. Having diabetes and being COVID-19-positive increases the risk of poor outcomes and death. Providers need to give anticipatory pharmacologic guidance to patients with diabetes during COVID-19 lockdown. Patients with diabetes need to be more observant than others and to use self-protective actions. This review (1) discusses the clinical observations of COVID-19, diabetes and underlying mechanisms, (2) describes special considerations in caring for patients with diabetes in a COVID-19 environment, and (3) reviews clinical implications for the health care provider. This review highlights current evidenced-based knowledge. Additional research regarding clinical management is warranted.
2019冠状病毒病(COVID-19)与患者糖尿病这两种大流行病与重症监护病房收治率高出2至3倍以及更高的死亡率相关。无论是居家隔离、新冠病毒检测呈阳性后被隔离,还是住院治疗,糖尿病患者在成功管理方面都需要特殊考虑。患有糖尿病且新冠病毒检测呈阳性会增加不良后果和死亡风险。在COVID-19封锁期间,医疗服务提供者需要为糖尿病患者提供预期的药物治疗指导。糖尿病患者需要比其他人更加注意,并采取自我保护措施。本综述(1)讨论了COVID-19、糖尿病的临床观察结果及潜在机制,(2)描述了在COVID-19环境中护理糖尿病患者的特殊考虑因素,(3)综述了对医疗服务提供者的临床意义。本综述突出了当前基于证据的知识。关于临床管理的更多研究是必要的。